PromoCell, a premier manufacturer of human primary cells and cell culture products, now offers cell disease models covering a wide range of diseases including diabetes type 1 and 2, respiratory diseases such as COPD and asthma, as well as cardiomyopathy disease. Relevant models enable experiments under physiologic conditions and are key for developing new therapies for chronic diseases. With its greater range of cell disease models, PromoCell underlines its role as a dedicated supporter of scientific research and innovation.
“PromoCell now offers a large selection of donor cells with known disease status that are suitable for drug discovery and research applications,” says Daniel Spatz, CBO of PromoCell. These disease cell types can be cultured using PromoCell’s matching growth media to ensure optimal growth performance. “Our diseased cells feature the same specifications and undergo the same rigid quality control tests as their healthy counterparts from our human primary cell portfolio,” adds Dr. Irma Boercsoek, COO of PromoCell. The tests include cell factors marker characterization, growth performance and morphology.
With its comprehensive portfolio of products and services for human cell culture, PromoCell supports scientists worldwide in advancing research and developing safer drugs. Today, PromoCell offers more than 7,000 human cell culture and cell biology products. As part of the human cell culture portfolio, the company offers human primary cells, stem cells and blood cells, as well as optimized products for cancer cell culture, including kits for 3D cell culture. PromoCell’s cell biology products are used for in-depth analysis of cells in culture. The portfolio includes high-quality kits and reagents for cell biology, such as antibodies, ELISAs, cytokines, and growth factors.
